Form 4 Tracker
Gary K. Lee

Chief Scientific Officer · 2 filings · Latest: Feb 11, 2026

Lyell Immunopharma, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
LYEL
Gary K. LeeChief Scientific OfficerFeb 11, 2026
Sale
$23.391,671$39.1K16,938
LYEL
Gary K. LeeChief Scientific OfficerFeb 10, 2026
Sale
$23.12147$3.4K18,609